Voice-Based AI for Diabetes Medication Titration

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current systems for managing type 2 diabetes, particularly for patients with poor glycemic control, face challenges in frequent medication adjustments and dose titrations, often due to therapeutic inertia and inadequate provider follow-through, especially with the increasing demand and labor shortages in healthcare.

Innovation Solution

A voice-based artificially intelligent system that uses a conversational AI model to receive clinical parameters, initiate and titrate GLP-1 agonist, biguanide, and SGLT-2 inhibitor drug regimens, allowing for remote patient management through a smart speaker, integrating with continuous glucose monitors and glucometers for real-time data processing and medication guidance.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If medication adjustments are made frequently to improve glycemic control, then patient outcomes improve, but provider workload and appointment time requirements increase

Engineering Contradiction:
Improveglycemic controlVSAvoidappointment time
Core Design Contradiction:
ReliabilityVSLoss of time

Solution Approach 1:

The system enables patients to self-manage their medication regimen by automatically receiving dosage instructions from the AI model based on their glucose data, eliminating the need for frequent provider visits to adjust medications

Inventive Principle:
Principle #25Self-service

Solution Approach 2:

The system continuously monitors patient glucose data and automatically adjusts medication dosages through closed-loop feedback, with the AI model receiving real-time data and generating updated dosage instructions without requiring manual provider intervention

Inventive Principle:
Principle #23Feedback

2Reliability

If more medication monitoring and adjustments are performed to reduce therapeutic inertia, then patient care quality improves, but provider labor requirements increase

Engineering Contradiction:
Improvemedication adherenceVSAvoidprovider labor efficiency
Core Design Contradiction:
ReliabilityVSProductivity

Solution Approach 1:

Patients independently manage their own medication regimens through the system, which automatically monitors adherence and adjusts dosages based on glucose data, freeing providers from routine medication management tasks

Inventive Principle:
Principle #25Self-service

Solution Approach 2:

The AI model replaces manual provider decision-making with automated algorithms that process glucose data and generate dosage instructions, substituting human labor with computational systems

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

3Reliability

If remote monitoring and frequent data processing are implemented to enable frequent dose titrations, then glycemic control improves, but system complexity and data processing requirements increase

Engineering Contradiction:
Improveglycemic controlVSAvoidsystem complexity
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The AI model serves multiple functions including processing glucose data, determining dosage instructions, generating patient communications, and monitoring adherence, consolidating what would otherwise require multiple separate systems into a single platform

Inventive Principle:
Principle #6Universality (Multi-functionality)

Solution Approach 2:

The system uses standardized data formats and interfaces as intermediaries to connect with various glucose monitoring devices, simplifying the integration of multiple data sources without increasing overall system complexity

Inventive Principle:
Principle #24Intermediary (Mediator)

Data Source

PatentUS12251242B1Voice-based method and system for management of type 2 diabetes
Publication Date: 2025.03.18 UPDOC INC
  • US12251242B1 patent drawing
  • US12251242B1 patent drawing
  • US12251242B1 patent drawing

AI summary

An artificially intelligent, voice-based method for prescribing, managing and administering at least one medication for management of type 2 diabetes to a patient. Aspects of the present disclosure provide for a system and method for configuring one or more clinical algorithms according to one or more clinical protocols to configure a conversational AI model. The conversational AI model is configured to drive a conversational AI agent configured to facilitate a plurality of multi-turn conversational interactions between a patient user and the conversational agent to enable automated initiation and titration of one or more diabetes medications for the patient.